Hennion & Walsh Asset Management, Inc. Novartis Ag Transaction History

Hennion & Walsh Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$92.57 - $107.37 $90,811 - $105,329	-981 Reduced 24.57%	3,012 $320,000
Q1 2024 Apr 17, 2024	BUY	$95.27 - $108.47 $11,241 - $12,799	118 Added 3.05%	3,993 $386,000
Q4 2023 Jan 10, 2024	BUY	$92.27 - $101.54 $1,199 - $1,320	13 Added 0.34%	3,875 $391,000
Q3 2023 Oct 27, 2023	SELL	$94.73 - $105.13 $48,691 - $54,036	-514 Reduced 11.75%	3,862 $393,000
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $13,600 - $15,421	147 Added 3.48%	4,376 $442,000
Q1 2023 Apr 20, 2023	BUY	$80.03 - $92.81 $31,691 - $36,752	396 Added 10.33%	4,229 $389,000
Q4 2022 Jan 12, 2023	BUY	$75.55 - $92.52 $63,990 - $78,364	847 Added 28.37%	3,833 $348,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $222,785 - $260,558	2,986 New	2,986 $227,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.